Company / Current Assets
Coherus Oncology, Inc. Current Assets History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$343.0M
FY2019
5-year range
$84.4M / $343.0M
FY2015-FY2019
Trend
+306.2%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets changed +306% YoY in FY2019, a notable deviation from the 5-year average annual change of +49%.
Based on SEC 10-K filings.
$343M in FY2019 with a 5-year CAGR of +13.9%.
Improved from $145M to $343M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +28.5%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +13.9%, indicating consistent growth.
- In FY2019, current assets increased 306.2% year-over-year.
- Lowest current assets in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $343.0M | +306.2% |
| FY2018 | $84.4M | -42.0% |
| FY2017 | $145.5M | -9.9% |
| FY2016 | $161.5M | -18.2% |
| FY2015 | $197.4M | +10.2% |
| FY2014 | $179.1M | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026